We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.15 | -4.35% | 3.30 | 3.20 | 3.40 | 3.45 | 3.30 | 3.45 | 73,034 | 09:14:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -2.37M | -0.0262 | -1.32 | 3.11M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/9/2021 08:33 | Would like to see them break past 40p this week at least. They deserve it | cparry1989 | |
29/9/2021 08:15 | deal has been done by Suzy! | fission453 | |
29/9/2021 08:15 | This will go to £1.00 plus prior to news on 201. Judging by the QA session yesterday, it's not if but when. | fission453 | |
29/9/2021 06:37 | Could be anything from 35 to 40p today and that’s just the start, what we will be com Christmas is anyone’s guess. | 412069 | |
28/9/2021 21:01 | More likely VAL and EOG. | luckyabbeygale | |
28/9/2021 20:40 | Val & Angs are the next two baggers - Mark me | ultimatejustice9 | |
28/9/2021 19:06 | Great post Base, thanks for the insight, onwards and upwards | tburns | |
28/9/2021 18:57 | Presentation very solid & Suzie & Kevin certainly give confidence that they are running a tight ship & have a cunning plan. So we have it confirmed that the deals/deals under discussion will follow the traditional format of up front licencing fee,milestone payments & royalties ( if & when commercialisation is achieved).The first 2 items are likely to have a total potential value written into the contract from the outset & the amount becomes the $64k question as , clearly, a $5mill deal with $500k up front & the balance in milestones is about 10% as attractive as a $50mill deal etc.The suggestion ,as 201 is still early stage , is that the up front payment will be not so large , due to the work remaining to be done but we can speculate for the next 3 months,which we surely will,but it will only be guesswork & hopefully it will at least cover our cash requirements for at least an additional year. Everyone seems to agree (inc me ) that focus on women s health is a good plan & it will be interesting to see whether that may infer confidence in a deal for 301 -which is very clearly focussed on a massive unmet need in ladies around the globe & , if successful , could be a major blockbuster, as there are currently few treatment options. With view to our tiny , & possibly shrinking , free float it will be interesting to see in what range our share price settles-especially if Cenkos put out a strong but=y recommendation to their clients as we have seen how our share price responds to relatively small increases in demand.Some existing holders will "top slice " as we rise, providing some liquidity but some of our new investors may be stickier than the old-although I cant see IIs being too interested as there just arent enough issued shares for them to build meaningful stakes. Hopefully will be viewed as a special situation & unaffected by the stock market malaise & uncertainties over the pond . Good luck all! | base7 | |
28/9/2021 17:56 | Unlike your wallet Nico after today and what is to come!! | tburns | |
28/9/2021 17:48 | Yes I need to lighten lol | nico115 | |
28/9/2021 17:47 | U happier now Nico ? | amaretto1 | |
28/9/2021 16:47 | Late buy of 222,882 reported at 30p | dope007 | |
28/9/2021 16:31 | Now that presentation has been given updates can come at any time on further progress, all bright here now and new 30p base rising to 35p tomorrow I feel. GLA | tburns | |
28/9/2021 16:26 | - New strategy imbedded - Fresh management team taken a different view, working on focused niche area of Women's Health - Active looking at new projects, the stats were something like 50 projects evaluated and 6 identified as potential - Focus on licensing out the Back Book, They have a total focus on that happening - VAL201, 301 and 401 all positioned well for licensing - Confident and on Track for licensing before the year end - Sufficient working capital with no desire for future placings, new strategy will see revenues increase - They have very much carved out a USP - The recent AZN deal shows massive demand in their fields - fantastic SH communication and desire to engage with investor audience, really refreshing Frankly, it could it have gone any better Pork's | porky9 | |
28/9/2021 16:24 | Brilliant news today. Well done suzy and team. Looking forward to a good steady increase | jasonpugh | |
28/9/2021 16:24 | Smashed it. | wapper | |
28/9/2021 16:16 | Back below 30 keep pumping boys | jaforsadi | |
28/9/2021 16:11 | Pump the dog pump it pump it | jaforsadi | |
28/9/2021 16:11 | Numpty, nothing being pumped here, the rise is based up the detail from the presentation and a lot further to go here. Market Capt should be treble where we are with 201 expected to be fleshed out this year. Plenty of upside still to come and will be a strong open tomorrow | tburns | |
28/9/2021 16:07 | You didn’t watch the webinar then eh. | 412069 | |
28/9/2021 16:03 | Pump pump pump the dog | jaforsadi | |
28/9/2021 16:03 | Where’s the doomers now ?? | 412069 | |
28/9/2021 16:01 | 30p paid, strong into the close it looks like | tburns |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions